Search Results - "Tkaczuk, K H R"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer

    196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer by Boni, V, Alemany, C, Meisel, J L, Sinha, R, Sterrenberg, D, Tkaczuk, K H R, Wang, Y, Wang, Z, Han, H S

    Published in Annals of oncology (01-05-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    SGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer

    SGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer by Boni, V., Alemany, C., Meisel, J.L., Sinha, R., Sterrenberg, D., Tkaczuk, K.H.R., Wang, Y., Wang, Z., Han, H.S.

    Published in Annals of oncology (01-05-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: